Safety and efficacy of robotic and thoracoscopic lobectomy in the treatment of early non-small cell lung cancer
10.3969/j.issn.1006-5725.2019.04.009
- VernacularTitle:机器人与胸腔镜肺叶切除术在治疗早期非小细胞肺癌的安全性与疗效对比
- Author:
Hongbo GUO
1
;
Bentong YU
Author Information
1. 南昌大学第一附属医院胸心外科
- Keywords:
robot lobectomy;
thoracoscopic lobectomy;
early stage non-small cell lung cancer;
safety;
effect
- From:
The Journal of Practical Medicine
2019;35(4):541-545
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the efficacy and safety of robotic lobectomy and thoracoscopic lobectomy in early stage non-small cell lung cancer. Methods From January 2016 to January 2018, 113 patients with early-stage non-small-cell lung cancer who met the inclusion criteria were included in the same surgical group of thoracic and cardiac surgery department of the first affiliated hospital of nanchang university. According to the surgical method, they were randomly divided into robot-assisted thoracoscopic surgery (57 cases) and conventional thoracoscopic surgery (56 cases). Preoperative age (± 5 years) and relevant basic medical history were used to match the patients. The lymph node ascending rate, operative time, preoperative preparation time, intraoperative blood loss, drainage time, postoperative pain score on the second day, postoperative hospitalization time and perioperative complications of the two groups were compared prospectively. Results There was no significant difference in lymph node ascending rate, operation time, pain score on the second day after surgery and lymph node clearance number between the two groups. Intraoperative blood loss, drainage time and postoperative hospitalization time were lower than that of the thoracoscopy group (P < 0.05). The complication rate of the robot group was significantly lower than that in the thoracoscopy group (10.5％ vs. 26.7％, P < 0.05). The preoperative preparation time of the robot group was higher than that of the thoracoscopic group (P < 0.05). Conclusion Robot lobectomy is better and safer in patients with early non-small cell lung cancer than thoracoscopic lobectomy, and can be used in clinical application.
